(Circulation. 2000;101:2345.)
© 2000 American Heart Association, Inc.
Brief Rapid Communications |
Abnormal Aortic Valve Development in Mice Lacking Endothelial Nitric Oxide Synthase
From the Division of Cardiology, Terrence Donnelly Heart Center, St Michael’s Hospital, University of Toronto, Ontario, Canada.
Correspondence to Duncan J. Stewart, MD, Dexter H.C. Man Chair and Director of Cardiology, University of Toronto, Terrence Donnelly Heart Center, St Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada, M5B 1W8. E-mail stewartd{at}smh.toronto.on.ca
 |
Abstract |
|---|
 Top Abstract IntroductionMethodsResultsDiscussionReferences |
|---|
Background—Endothelium-derived nitric oxide (NO) is produced by an oxidative reaction catalyzed by endothelial NO synthase (eNOS). NO plays a crucial role in controlling cell growth and apoptosis, as well as having well-characterized vasodilator and antithrombotic actions. More recently, endothelium-derived NO was shown to be involved in postdevelopmental vascular remodeling and angiogenesis, as well as in the formation of limb vasculature during embryogenesis. Therefore, we investigated the role of endothelium-derived NO during cardiovascular development using mice deficient in eNOS.
Methods and Results—We examined the hearts of 12 mature eNOS-deficient and 26 mature wild-type mice. Five of the mature eNOS-deficient mice had a bicuspid aortic valve; none of the 26 wild-type animals exhibited identifiable valvular or cardiac abnormalities. Immunohistochemical analysis revealed prominent eNOS expression localized to the endothelium lining the valve cusps of the aorta in mature wild-type mice; expression was localized to the myocardium and endothelial cell monolayer lining the valve leaflets in the developing embryo.
Conclusions—These results show a strong association between eNOS deficiency and the presence of a bicuspid aortic valve; they provide the first molecular insight into one of the most common types of congenital cardiac abnormality.
Key Words: nitric oxide • endothelium • mice, knockout • heart defects, congenital • valves
|
Introduction |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Nitric oxide (NO) is a free radical gas that is synthesized from L-arginine in a complex oxidative reaction catalyzed by 3 distinct isoforms of NO synthase: endothelial (eNOS), inducible (iNOS), and neuronal (nNOS).1 The neuronal isoform is highly expressed in neuronal cells and skeletal muscle, whereas the endothelial isoform is predominantly expressed in endothelial cells and produces small amounts of NO in response to intimal shear stress or agonists such as bradykinin.2 3 The inducible isoform is expressed in many cell types, including macrophages and smooth muscle cells, primarily in response to inflammatory cytokines. Once expressed, this isoform can produce large amounts of NO in a continuous manner.1 2 Endothelium-derived NO is crucial in the regulation of cell growth and apoptosis; it also has a well-characterized role as a vasodilator and antithrombotic agent.1 More recently, NO derived from the endothelium was shown to be involved in postdevelopmental vascular remodeling and angiogenesis, as well as in the formation of limb vasculature during embryogenesis.4 5 6
The valve leaflets of the heart originate from mesenchymal outgrowths known as cardiac cushions. Cushion formation is localized to the atrioventricular canal and ventricular outflow tract regions of the primary heart tube. These formations arise from regional thickenings of the cardiac jelly, the extracellular matrix that resides between the myocardium and endocardium of the primitive heart tube. This event involves the transformation of a subset of endothelial cells of the endocardium into mesenchyme. The molecular mechanisms and the possible role of the endothelium in this developmental process remain largely unexplored. We report here that mice lacking functional eNOS demonstrate a high incidence of bicuspid aortic valves; this provides the first evidence for the involvement of endothelium-derived NO in cardiac valve morphogenesis.
|
Methods |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Mice
Wild-type (n=29) and eNOS knockout (n=27) mice of the C57BL/6J genetic background were obtained from Jackson Laboratories (Bar Harbor, ME). Male mice weighing 25 to 30 g and embryos at day 13.5 of gestation were used for analysis. The use and care of mice were in accordance with the guidelines of the Canadian Council of Animal Care.
Histology and Immunohistochemistry
Serial sections of the hearts and aortas from mature knockout
(n=12) and wild-type (n=26) mice were collected after perfusion
fixation with saline and 10% buffered formalin. Embryos from knockout
(n=8) and wild-type (n=8) mice were isolated and fixed in 10% buffered
formalin. Immunohistochemistry was performed using a monoclonal
antibody specific for eNOS (1:1000 dilution, Transduction
Laboratories) and visualized using the avidin-biotin
immunoperoxidase complex and diaminobenzidine. For a negative control,
the primary antibody was substituted with nonimmune mouse serum.
Vascular Casting
A methylmethacrylate casting compound (Polysciences) was infused
retrograde into the abdominal aorta of mature knockout (n=15) and
wild-type (n=3) mice at a constant physiological
pressure. The cast was allowed to set for 30 minutes, and the tissue
was dissolved by immersion into a saturated solution of potassium
hydroxide.
|
Results |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
Of the 12 adult eNOS-deficient mice examined, 5 had a bicuspid aortic valve, whereas none of the 26 wild-type C57BL/6J animals exhibited identifiable valvular or cardiac abnormalities (Figures 1A
and 1B). Immunohistochemical
analysis revealed prominent eNOS expression localized to the
endothelium lining the valve cusps of the aorta in
adult mice, but no staining was seen in either the mature eNOS knockout
mice or negative controls (Figures 1C through 1E). Measurements
from vascular casts at the 5 levels depicted in Figure 2 showed no differences in aortic lumen
diameter between mutant and wild-type mice
(Table). Furthermore,
representative casts of the aorta and its major
branches in mature mice showed no evidence of aortic coarctation
(Figure 2). In the small number of mutant and wild-type embryos
examined, there was no evidence of the presence of severe cardiac
abnormalities (Figures 3A and 3B). In the
developing embryo at day 13.5 of gestation, immunohistochemical
examination revealed prominent eNOS staining localized to the
myocardium and the endothelial cell
monolayer lining the valve leaflets (Figure 3C). Staining for
eNOS was not observed in the negative control (Figure 3D).
|
|
|
|
|
Discussion |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
A bicuspid aortic valve is one of the most common forms of human birth defect in which familial clustering has been described; it occurs in
1% of newborn infants.7 8 Although bicuspid aortic
valves can be functionally normal, this congenital abnormality accounts
for a substantial disease burden because of a propensity toward
complications, including aortic stenosis and bacterial
endocarditis, which often lead to valve failure. A functionally normal
bicuspid valve may also develop progressive incompetence; therefore, it
is an important cause of anatomically isolated aortic
regurgitation in adults.9
The use of targeted gene disruption has provided valuable insight into
the molecular basis of cardiovascular development. A
number of these genetic mutations have resulted in severe cardiac
abnormalities that have led to embryonic death. In the present
study, we showed that mice lacking functional eNOS are predisposed to
developing a bicuspid aortic valve, a condition that has never before
been reported in mice. Insights previously gained from eNOS-deficient
mice support a role for endothelium-derived NO as a
major mediator of vascular remodeling and angiogenesis.4 5
Furthermore, the expression of eNOS is increased during early
cardiomyogenesis, and NOS inhibitors prevent the maturation
of terminally differentiated cardiomyocytes in an embryonic
stem cell system, which suggests a possible role for NO in cardiac
development.10 Mice deficient in eNOS also possess limb
reduction defects, possibly due to vascular insufficiency. These limb
abnormalities were seen in 
10% of the null animals, and they
resemble the limb reduction defects seen in patients with Holt-Oram
Syndrome.6 11 Recently, a novel heart-hand syndrome was
described; it consisted of a patent ductus arteriosus, a bicuspid
aortic valve, hand abnormalities, and pseudocoarctation of the
aorta.12 The presence of a bicuspid aortic valve, together
with abnormal limb development in the eNOS knockout mouse, suggests
that altered NO activity may contribute either directly or indirectly
to the heart-hand abnormalities seen in some patients.
The mechanism by which an eNOS deficiency contributes to the formation
of a bicuspid aortic valve remains to be determined. It is possible
that the valvular endothelium is responsible
for transducing luminal events, such as shear stress, and generating
signals that fine-tune the developmental program of the primitive
ventricular outflow tract to ensure the formation of a
normal, low-profile tricuspid structure. Given that NO has been
implicated in vascular remodeling in response to changes in luminal
flow conditions, it is also reasonable to speculate that a lack of eNOS
may also interfere with the remodeling of the aortic isthmus during the
transition from the fetal to the adult pattern of
circulation.4 Interestingly, a bicuspid aortic valve is
found in 50% of patients with coarctation of the
aorta.13 In the present study, there was no evidence
of aortic coarctation in the 15 eNOS-deficient mice examined. However,
a bicuspid aortic valve is a far more common clinical condition than
aortic coarctation and, therefore, a much larger number of animals
would be needed to exclude the possibility of a low incidence of
coexisting aortic coarctation in these animals.
The present results show a strong association between eNOS deficiency and the presence of a bicuspid aortic valve, and they provide the first molecular insight into the development of this congenital cardiac abnormality. Further experiments are required to elucidate the precise mechanisms by which endothelium-derived NO modulates valve morphogenesis in the developing embryo.
|
Acknowledgments |
|---|
This work was supported by the Medical Research Council of Canada (MT11620). The authors thank Drs Lowell Langille and Lee Adamson for their assistance with vascular casting and embryo analysis. They are also grateful to Olivia Chan and Kalesha Hack for their technical assistance during the course of this study. Dr Lee is a member of the Cardiovascular Sciences Collaborative Program and is supported by a studentship from the Canadian Hypertension Society/Pfizer Canada/Medical Research Council of Canada.
Received January 26, 2000; revision received March 23, 2000; accepted March 28, 2000.
|
References |
|---|
|
TopAbstractIntroductionMethodsResultsDiscussionReferences |
|---|
1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med. 1993;329:2002–2012.
2. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell. 1994;78:915–918.[Medline] [Order article via Infotrieve]
3.
Chang WJ, Iannaccone ST, Lau KS, et al.
Neuronal nitric oxide synthase and dystrophin-deficient muscular
dystrophy. Proc Natl Acad Sci U S A. 1996;93:9142–9147.
4. Rudic RD, Shesely EG, Maeda N, et al. Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest. 1998;101:731–736.[Medline] [Order article via Infotrieve]
5. Murohara T, Asahara T, Silver M, et al. Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest. 1998;101:2567–2578.[Medline] [Order article via Infotrieve]
6. Gregg AR, Schauer A, Shi O, et al. Limb reduction defects in endothelial nitric oxide synthase-deficient mice. Am J Physiol. 1998;275:H2319–H2324.
7. Roberts WC. The congenitally bicuspid aortic valve: a study of 85 autopsy cases. Am J Cardiol. 1970;26:72–83.[Medline] [Order article via Infotrieve]
8. Huntington K, Hunter AG, Chan KL. A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. J Am Coll Cardiol. 1997;30:1809–1812.[Abstract]
9. Olson LJ, Subramanian R, Edwards WD. Surgical pathology of pure aortic insufficiency: a study of 225 cases. Mayo Clin Proc. 1984;59:835–841.[Medline] [Order article via Infotrieve]
10.
Bloch W, Fleischmann BK, Lorke DE, et al. Nitric oxide
synthase expression and role during cardiomyogenesis. Cardiovasc
Res. 1999;43:675–684.
11.
Basson CT, Cowley GS, Solomon SD, et al. The clinical
and genetic spectrum of the Holt-Oram syndrome (heart-hand syndrome).
N Engl J Med. 1994;330:885–891.
12. Gelb BD, Zhang J, Sommer RJ, et al. Familial patent ductus arteriosus and bicuspid aortic valve with hand anomalies: a novel heart-hand syndrome. Am J Med Genet. 1999;87:175–179.
13.
Becker AE, Becker MJ, Edwards JE. Anomalies associated
with coarctation of aorta: particular reference to infancy.
Circulation. 1970;41:1067–1075.
This article has been cited by other articles:
 |
|
 |
|
  B. Fernandez, A. C. Duran, T. Fernandez-Gallego, M. C. Fernandez, M. Such, J. M. Arque, and V. Sans-Coma Bicuspid aortic valves with different spatial orientations of the leaflets are distinct etiological entities. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2312 - 2318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. H. Anderson, R. P. Thompson, and C. B. Kern Development of aortic valves with 2 and 3 leaflets. J. Am. Coll. Cardiol., December 8, 2009; 54(24): 2319 - 2320. [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Coady and F. W. Sellke Metallothionein Link to Bicuspid Aortic Valve-Associated Ascending Aortic Dilatation Circulation, May 12, 2009; 119(18): 2423 - 2425. [Full Text] [PDF]
|
|
|
|
|
|
T. M. Tadros, M. D. Klein, and O. M. Shapira Ascending Aortic Dilatation Associated With Bicuspid Aortic Valve: Pathophysiology, Molecular Biology, and Clinical Implications Circulation, February 17, 2009; 119(6): 880 - 890. [Full Text] [PDF]
|
|
|
|
 |
|
 A.-M. Teichert, J. A. Scott, G. B. Robb, Y.-Q. Zhou, S.-N. Zhu, M. Lem, A. Keightley, B. M. Steer, A. C. Schuh, S. L. Adamson, et al. Endothelial Nitric Oxide Synthase Gene Expression During Murine Embryogenesis: Commencement of Expression in the Embryo Occurs With the Establishment of a Unidirectional Circulatory System Circ. Res., July 3, 2008; 103(1): 24 - 33. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Borer and L. N. Girardi Repair of the congenitally bicuspid regurgitant aortic valve a strategic advance. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 50 - 51. [Full Text] [PDF]
|
|
|
|
|
|
Y. Bosse, P. Mathieu, and P. Pibarot Genomics: The Next Step to Elucidate the Etiology of Calcific Aortic Valve Stenosis J. Am. Coll. Cardiol., April 8, 2008; 51(14): 1327 - 1336. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. B. Donnelly Cardiac Valvular Pathology: Comparative Pathology and Animal Models of Acquired Cardiac Valvular Diseases Toxicol Pathol, February 1, 2008; 36(2): 204 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. C. W. Groenendijk, K. Van der Heiden, B. P. Hierck, and R. E. Poelmann The Role of Shear Stress on ET-1, KLF2, and NOS-3 Expression in the Developing Cardiovascular System of Chicken Embryos in a Venous Ligation Model Physiology, December 1, 2007; 22(6): 380 - 389. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M C Pustovrh, A Jawerbaum, V White, E Capobianco, R Higa, N Martinez, J J Lopez-Costa, and E Gonzalez The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats Reproduction, October 1, 2007; 134(4): 605 - 613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Sierro, C. Biben, L. Martinez-Munoz, M. Mellado, R. M. Ransohoff, M. Li, B. Woehl, H. Leung, J. Groom, M. Batten, et al. Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7 PNAS, September 11, 2007; 104(37): 14759 - 14764. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Matt, A. von Orelli, F. Bernet, T. Grussenmeyer, I. Lefkovits, and H.-R. Zerkowski Proteomics of Ascending Aortic Aneurysm with Bicuspid or Tricuspid Aortic Valve Asian Cardiovasc Thorac Ann, June 1, 2007; 15(3): 185 - 190. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Aicher, C. Urbich, A. Zeiher, S. Dimmeler, and H.-J. Schafers Endothelial Nitric Oxide Synthase in Bicuspid Aortic Valve Disease Ann. Thorac. Surg., April 1, 2007; 83(4): 1290 - 1294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Lepic, D. Burger, X. Lu, W. Song, and Q. Feng Lack of endothelial nitric oxide synthase decreases cardiomyocyte proliferation and delays cardiac maturation Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1240 - C1246. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Aboulhosn and J. S. Child Left Ventricular Outflow Obstruction: Subaortic Stenosis, Bicuspid Aortic Valve, Supravalvar Aortic Stenosis, and Coarctation of the Aorta Circulation, November 28, 2006; 114(22): 2412 - 2422. [Full Text] [PDF]
|
|
|
|
 |
|
 R. Majumdar, M. Yagubyan, G. Sarkar, M. E. Bolander, and T. M. Sundt III Bicuspid aortic valve and ascending aortic aneurysm are not associated with germline or somatic homeobox NKX2-5 gene polymorphism in 19 patients J. Thorac. Cardiovasc. Surg., June 1, 2006; 131(6): 1301 - 1305. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Warnes The Adult With Congenital Heart Disease: Born To Be Bad? J. Am. Coll. Cardiol., July 5, 2005; 46(1): 1 - 8. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. C.W. Groenendijk, B. P. Hierck, J. Vrolijk, M. Baiker, M. J.B.M. Pourquie, A. C. Gittenberger-de Groot, and R. E. Poelmann Changes in Shear Stress-Related Gene Expression After Experimentally Altered Venous Return in the Chicken Embryo Circ. Res., June 24, 2005; 96(12): 1291 - 1298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Verma, P. E. Szmitko, P. W. M. Fedak, L. Errett, D. A. Latter, and T. E. David Can statin therapy alter the natural history of bicuspid aortic valves? Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2547 - H2549. [Full Text] [PDF]
|
|
|
|
|
|
S. Kanno, P. K. M. Kim, K. Sallam, J. Lei, T. R. Billiar, and L. L. Shears II Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells PNAS, August 17, 2004; 101(33): 12277 - 12281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y.-Q. Zhou, F. S. Foster, B. J. Nieman, L. Davidson, X. J. Chen, and R. M. Henkelman Comprehensive transthoracic cardiac imaging in mice using ultrasound biomicroscopy with anatomical confirmation by magnetic resonance imaging Physiol Genomics, July 8, 2004; 18(2): 232 - 244. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. N.N. Han, S. Babaei, M. Robb, T. Lee, R. Ridsdale, C. Ackerley, M. Post, and D. J. Stewart Defective Lung Vascular Development and Fatal Respiratory Distress in Endothelial NO Synthase-Deficient Mice: A Model of Alveolar Capillary Dysplasia? Circ. Res., April 30, 2004; 94(8): 1115 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. L. Macatee, B. P. Hammond, B. R. Arenkiel, L. Francis, D. U. Frank, and A. M. Moon Ablation of specific expression domains reveals discrete functions of ectoderm- and endoderm-derived FGF8 during cardiovascular and pharyngeal development Development, December 22, 2003; 130(25): 6361 - 6374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C A Warnes Bicuspid aortic valve and coarctation: two villains part of a diffuse problem Heart, September 1, 2003; 89(9): 965 - 966. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Babaei, K. Teichert-Kuliszewska, Q. Zhang, N. Jones, D. J. Dumont, and D. J. Stewart Angiogenic Actions of Angiopoietin-1 Require Endothelium-Derived Nitric Oxide Am. J. Pathol., June 1, 2003; 162(6): 1927 - 1936. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Ou, Z. Ou, D. G. McCarver, R. N. Hines, K. T. Oldham, A. W. Ackerman, and K. A. Pritchard Jr. Trichloroethylene Decreases Heat Shock Protein 90 Interactions with Endothelial Nitric Oxide Synthase: Implications for Endothelial Cell Proliferation Toxicol. Sci., May 1, 2003; 73(1): 90 - 97. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. T. Nkomo, M. Enriquez-Sarano, N. M. Ammash, L. J. Melton III, K. R. Bailey, V. Desjardins, R. A. Horn, and A. J. Tajik Bicuspid Aortic Valve Associated With Aortic Dilatation: A Community-Based Study Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 351 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. L. Brutsaert Cardiac Endothelial-Myocardial Signaling: Its Role in Cardiac Growth, Contractile Performance, and Rhythmicity Physiol Rev, January 1, 2003; 83(1): 59 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Zhao, X. Lu, and Q. Feng Deficiency in endothelial nitric oxide synthase impairs myocardial angiogenesis Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2371 - H2378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W.M. Fedak, S. Verma, T. E. David, R. L. Leask, R. D. Weisel, and J. Butany Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve Circulation, August 20, 2002; 106(8): 900 - 904. [Full Text] [PDF]
|
|
|
|
|
|
Q. Feng, W. Song, X. Lu, J. A. Hamilton, M. Lei, T. Peng, and S.-P. Yee Development of Heart Failure and Congenital Septal Defects in Mice Lacking Endothelial Nitric Oxide Synthase Circulation, August 13, 2002; 106(7): 873 - 879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. W. M. Fedak, S. Verma, J. Butany, R. D. Weisel, and T. E. David Aortic valve malformations and pulmonary autograft root dilatation J. Thorac. Cardiovasc. Surg., June 1, 2002; 123(6): 1222 - 1223. [Full Text] [PDF]
|
|
|
|
 |
|
 B. C Kone Molecular biology of natriuretic peptides and nitric oxide synthases Cardiovasc Res, August 15, 2001; 51(3): 429 - 441. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Shi, X. Wang, D. M. Shih, V. E. Laubach, M. Navab, and A. J. Lusis Paradoxical Reduction of Fatty Streak Formation in Mice Lacking Endothelial Nitric Oxide Synthase Circulation, April 30, 2002; 105(17): 2078 - 2082. [Abstract] [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||